药品注册申请号:019814
申请类型:NDA (新药申请)
申请人:ALLERGAN
申请人全名:ALLERGAN PHARMACEUTICAL
产品信息
产品号商品名活性成分剂型/给药途径规格/剂量参比药物(RLD)生物等效参考标准(RS)治疗等效代码该申请号批准日期该产品号批准日期市场状态
001 BETAGAN LEVOBUNOLOL HYDROCHLORIDE SOLUTION/DROPS;OPHTHALMIC 0.25% Yes Yes AT 1989/06/28 1989/06/28 Prescription
批准历史,通知信,药品说明书,综述等审批信息
批准日期申请类型申请提交号审查批准结论申请内容分类审评分类(优先审评;罕用药状态)通知信、综述、标签、说明书备注
2003/03/19 SUPPL 17 Approval Labeling STANDARD
2002/04/12 SUPPL 15 Approval Manufacturing (CMC) STANDARD
2001/12/04 SUPPL 14 Approval Manufacturing (CMC) STANDARD
2001/08/08 SUPPL 12 Approval Manufacturing (CMC) STANDARD
2001/05/14 SUPPL 11 Approval Labeling STANDARD
2001/04/12 SUPPL 13 Approval Manufacturing (CMC) STANDARD
2000/10/02 SUPPL 10 Approval Manufacturing (CMC) STANDARD
1999/01/21 SUPPL 7 Approval Manufacturing (CMC) STANDARD
1998/05/01 SUPPL 9 Approval Manufacturing (CMC) STANDARD
1997/09/18 SUPPL 8 Approval Manufacturing (CMC) STANDARD
1995/08/03 SUPPL 4 Approval Manufacturing (CMC) STANDARD
1995/06/14 SUPPL 5 Approval Manufacturing (CMC) STANDARD
1995/06/12 SUPPL 6 Approval Manufacturing (CMC) STANDARD
1992/02/03 SUPPL 3 Approval Labeling
1990/01/18 SUPPL 2 Approval Labeling
1990/01/04 SUPPL 1 Approval Manufacturing (CMC) STANDARD
1989/06/28 ORIG 1 Approval Type 3 - New Dosage Form STANDARD
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号专利号专利过期日是否物质专利是否产品专利专利用途代码撤销请求提交日期专利下载备注
与本品相关的市场独占权保护信息
关联产品号独占权代码失效日期备注
与本品治疗等效的药品
活性成分:LEVOBUNOLOL HYDROCHLORIDE 剂型/给药途径:SOLUTION/DROPS;OPHTHALMIC 规格:0.25% 治疗等效代码:AT
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
019814 001 NDA BETAGAN LEVOBUNOLOL HYDROCHLORIDE SOLUTION/DROPS;OPHTHALMIC 0.25% Prescription Yes Yes AT 1989/06/28 ALLERGAN
074779 001 ANDA AKBETA LEVOBUNOLOL HYDROCHLORIDE SOLUTION/DROPS;OPHTHALMIC 0.25% Prescription No No AT 1996/10/29 AKORN
更多信息
药品NDC数据与药品包装、标签说明书
©2006-2020 DrugFuture->U.S. FDA Drugs Database